Trial for advanced heart weakness with low pumping ability
Part of Heart & circulation clinical trials.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- Your heart pumping strength (left ventricular ejection fraction, or LVEF) is 40% or less
- You have widespread coronary artery disease—doctors rate this as high risk (a “jeopardy score” of 6 or more)
- You have not had a heart attack with ECG changes (STEMI) in the past 72 hours
- You have not had a stent procedure (PCI) in the past 3 months
- Your bleeding risk is not too high, and you can safely take long-term two blood thinners together
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to improve blood flow in people with weakened heart pumping (ischemic cardiomyopathy): bypass surgery (CABG) versus stent treatment (PCI). It aims to see which approach works better when the heart still has enough at-risk muscle and when best medical therapy is already started.
This study tracks patients with weakened heart function who undergo complex stent procedures (PCI) instead of open-heart surgery. Researchers will follow your progress to understand how well these procedures work in patients who are too sick for traditional bypass surgery.
This trial compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stents (PCI)—in people whose heart pumps weakly (LVEF 40% or less). It aims to find which method works better for chest pain or recent heart issues.
This study compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stent procedure (PCI)—in people with a weak pumping heart. It looks at which approach works best when the heart muscle is not pumping well and there are multiple blocked heart arteries.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.